Genetic Resilience

An analysis of the genomes of nearly 600,000 healthy individuals reveals a handful of people who appear resistant to certain genetic disorders.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

NHGRI, DARRYL LEJAMost genomic studies to date have focused on linking mutations to diseases. Taking a new approach, researchers studying the genomes of apparently healthy individuals identified some people who seem to be resilient to severe genetic disorders that are known to crop up during childhood. Of the 589,306 human genomes they analyzed, researchers from the Icahn School of Medicine at Mount Sinai in New York City and their colleagues identified 13 people who carry mutations for certain genetic disorders but do not appear to have the associated diseases, according to a study published today (April 11) in Nature Biotechnology.

“It’s a really interesting study because what we consider pathogenic [is] not necessarily the case,” Eric Topol, the director of the Scripps Translational Science Institute who was not involved with the study, told The Scientist. There have been several reports of people with severe, pathogenic mutations who did not show signs of the disease. “What’s new here is they took a systematic approach,” Topol said.

“If you wanted to find clues to prevention,” study coauthor Stephen Friend, president of the nonprofit Sage Bionetworks and a geneticist Mount Sinai, said during a press briefing, “instead of looking at people with disease, you would want to look at individuals who should have gotten sick.”

For the present study, Friend and colleagues analyzed existing data from 12 genetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tanya Lewis

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo